Last reviewed · How we verify
NCT06923878: CRD
Comparison of Skin Prick Testing, Extract-specific IgE Antibody Testing and Component Resolved Diagnosis in Diagnosing of Legume Allergy
trial in Food Allergy Suspected in 100 participants. Currently enrolling.
1 October 2028
Quick facts
| Lead sponsor | University Hospital Pilsen |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 October 2023 |
| Primary completion | 1 October 2028 |
| Estimated completion | 31 March 2029 |
| Sites | 1 location across Czechia |
Conditions studied
- Food Allergy Suspected — all drugs for Food Allergy Suspected →
Sponsor
University Hospital Pilsen
Who can join
Adults 4 Months to 65, any sex, with Food Allergy Suspected. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is aimed at improving the diagnosis of food allergy, specifically allergy to commonly consumed legumes such as peas, lentils, chickpeas or green beans. Patients suspected of allergy to these legumes will be examined using traditional methods of IgE-mediated allergy diagnosing (skin prick test, testing for specific IgE antibodies against food extract), but also by testing for specific IgE antibodies against relevant allergenic molecules of these legumes. The results of performed tests will be compared with the result of the oral food challenge, which is considered to be the gold standard of food allergy diagnosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06923878
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital Pilsen trials
Trials by the same sponsor.
- NCT07285915 — The Role of Stress in Cardiac Arrest (Cortizol CPR) · NA · not yet recruiting
- NCT07160153 — Cannabis Abstinence and Neurocognitive Assessment in Adolescence · recruiting
- NCT06634069 — Study SOLACE SEPSIS · Phase 2 · recruiting
- NCT06629701 — A Prospective Randomized Trial of External Vein Graft Support in Surgical Myocardial Revascularization · NA · enrolling by invitation
- NCT04838418 — Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06923878 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Pilsen
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06923878.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing